May
4
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
WESTMINSTER, Colo.–(BUSINESS WIRE)–May 4, 2026– TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company...